Harmony Biosciences (NASDAQ: HRMY) revenue
Harmony Biosciences reported revenue of $868.5m for fiscal 2025, 21.5% more than in fiscal 2024 ($714.7m). Since fiscal 2019 its revenue has grown by 14,386.3%, an average growth of 129.2% a year.
Harmony Biosciences has grown its revenue for 6 years in a row, and fiscal 2025 is the highest of its 7 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $868.5m | +21.5% | $208.5m | 24.0% |
| 2024 | $714.7m | +22.8% | $190.8m | 26.7% |
| 2023 | $582.0m | +32.9% | $192.0m | 33.0% |
| 2022 | $437.9m | +43.4% | $120.2m | 27.4% |
| 2021 | $305.4m | +91.2% | $87.5m | 28.7% |
| 2020 | $159.7m | +2,564.6% | $17.0m | 10.6% |
| 2019 | $6.0m | — | −$145.9m | −2,433.8% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Harmony Biosciences revenue compared with its sector
By revenue for its latest fiscal year, Harmony Biosciences ranks 162nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Harmony Biosciences, 21.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 160th | Warby Parker | $871.9m | 13.0% |
| 161st | Neogen | $870.4m | −2.7% |
| 162nd | Harmony Biosciences | $868.5m | 21.5% |
| 163rd | Varex Imaging | $844.6m | 4.1% |
| 164th | Arrowhead Pharmaceuticals | $829.4m | 23,258.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Harmony Biosciences
- How much revenue did Harmony Biosciences make in fiscal 2025?
- Harmony Biosciences reported revenue of $868.5m for fiscal 2025, compared with $714.7m in fiscal 2024.
- How much has the revenue of Harmony Biosciences grown?
- Between fiscal 2019 and fiscal 2025 it went from $6.0m to $868.5m: 14,386.3% more, an average growth of 129.2% a year.
- What was the best year for revenue at Harmony Biosciences?
- Of its last 7 fiscal years, fiscal 2025, with $868.5m.
- Where does Harmony Biosciences rank in its sector by revenue?
- It ranks 162nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Harmony Biosciences come from?
- From the annual report (Form 10-K) that Harmony Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Harmony Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Harmony Biosciences: the Harmony Biosciences page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.